Cimzia is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Ucb, Inc.. The primary component is Certolizumab Pe.
| Product ID | 50474-710_119e849c-fc70-44d1-883f-1c977c869e17 |
| NDC | 50474-710 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cimzia |
| Generic Name | Certolizumab Pegol |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2009-05-14 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125160 |
| Labeler Name | UCB, Inc. |
| Substance Name | CERTOLIZUMAB PE |
| Active Ingredient Strength | 200 mg/mL |
| Pharm Classes | Tumor Necrosis |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2009-05-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125160 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-05-14 |
| Marketing Category | BLA |
| Application Number | BLA125160 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2009-05-14 |
| Marketing Category | BLA |
| Application Number | BLA125160 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-05-14 |
| Ingredient | Strength |
|---|---|
| CERTOLIZUMAB PEGOL | 200 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50474-700 | Cimzia | certolizumab pegol |
| 50474-710 | Cimzia | certolizumab pegol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CIMZIA 86685372 4944726 Live/Registered |
UCB PHARMA, S.A. 2015-07-07 |
![]() CIMZIA 85586588 4217932 Live/Registered |
UCB PHARMA, S.A. 2012-04-02 |
![]() CIMZIA 79028492 3298318 Dead/Cancelled |
UCB PHARMA, S.A. 2006-06-22 |
![]() CIMZIA 78229684 3248891 Live/Registered |
UCB PHARMA, S.A. 2003-03-25 |